Global Market of Automated Suturing Devices is expected to reach USD 4.50 billion in 2023 from USD 2.95 billion in 2016 with a CAGR of approximately 7.2% during the forecast period 2017-2023.

Global Market of Automated Suturing Devices is expected to reach USD 4.50 billion in 2023 from USD 2.95 billion in 2016 with a CAGR of approximately 7.2% during the forecast period 2017-2023.

automated suturing devices Market
Market Research Future, compiled report on ‘Global Automated Suturing Devices Market’ delivers a holistic view on market valuations, market size, profit estimations, SWOT analysis and regional landscape of the market. In addition, the report points out key challenges and growth opportunities, while examining the current competitive standings of key players during the forecasted timeline.

Key players in the automated devices market are Ethicon Inc. (Subsidiary of Johnson & Johnson) (U.S.), B. Braun Melsungen AG (Germany), Medtronic plc. (Ireland), DemeTECH Corporation (U.S.),  Smith & Nephew plc (U.K.), Péters Surgical (France), EndoEvolution LLC (U.S.),  Boston Scientific Corporation (U.S.) and Sutures India Pvt. Ltd. (India). The main focus of these players is tapping the market in developing regions across the globe.

Key developments:

Strategic approaches adopted help the major players in the market to sustain their growth and develop their business in various geographical areas across the globe. Agreements and collaborations, mergers and acquisitions, and new product launches are various strategies followed by the key players.

Surgical sutures devices are used for wound closure or repair injuries. These devices have their application in ophthalmology, orthopedic, gynecology, cardiovascular surgery, orthopedic surgery, laparoscopy and other specialties in healthcare. Surgical suture devices can be automated or manually used suture devices. Suture needle is primarily used for surgical site closure. Automated devices can be disposable or reusable. Disposable surgical suture devices are most widely used because of safety concerns to the patient and prevention of surgical site infection.

Avail Sample Copy before Purchase at:

Sutures are sterile surgical instruments used for the closure of surgical incision or wound. Sutures are either automated or manually operated devices. Demand for automated suturing devices is increasing due to an increase in the number of surgeries performed in the hospital, demand of safe closure of surgical site, prevention of hospital acquired infection, and improved quality of healthcare.

Intended Audience

  • Medical device manufacturers
  • Medical device suppliers
  • Contract Research Organizations (CROs)
  • Research and Development (R&D) Companies
  • Academic Medical Institutes and Universities

There is an increasing demand for automated suturing devices in the market owing to an increasing number of surgical procedures in hospitals and rising prevalence of chronic diseases. The market is further stimulated by a technology advancement in surgical devices having applications in various fields of medicine such as dentistry, gynaecology, cardiology, urology, and others.

Ethicon Inc.:

Ethicon Inc. is a subsidiary of Johnson & Johnson, manufacturing surgical sutures and wound closure devices. Enseal X1 is a suturing devices designed for use in open surgical procedures. Harmonic HD 1000 is designed of laparoscopic surgery.

February 2017: Ethicon, Inc. today announced an agreement to acquire Torax Medical, Inc., a private medical device company manufacturing and marketing the LINX Reflux Management System, a novel minimally invasive device for the surgical treatment of GERD. This acquisition will enable the company to offer patients effective alternative to the anatomy-altering laparoscopic Nissen fundoplication surgical procedure. LINX Reflux Management System comprises of interlinked titanium beads with magnetic cores. LINX is currently used by physicians in over 300 hospitals in the U.S. and Europe. This acquisition is a part of strategic approach advancement in innovation and investment in esophageal health.

Brows full Detailed Report at:

Braun Melsungen AG:

Braun Melsungen AG is a medical and pharmaceutical device company.

Safil parenchyma Set, Securex, Securex are special suture sets offered by the company.

April 2017: B. Braun Melsungen AG announced the launch of new home infusion therapy application that will help healthcare professionals and patients. This app allows infusion therapy nurses to educate the patients to use Easypump at their own homes.

October, 2015: B. Braun Medical Inc., announced that it will the launch its latest advancement in echogenic peripheral nerve block needle technology at American Society of Anesthesiologists (ASA) Annual Meeting at the San Diego Convention Center. The product “Stimuplex Ultra 360” denotes an key advancement in regional anesthesia.

Inquire for Discount at:

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India